XML 54 R39.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Tables)
9 Months Ended
Apr. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of stock-based awards outstanding by award type
As of April 30, 2024, the following stock-based awards, by award type, were outstanding:
 April 30, 2024
Stock options170,150 
Performance shares379,353 
RSUs, restricted stock, share units and other stock-based awards1,012,484 
Total1,561,987 
Stock-based compensation for awards detailing where recorded in Consolidated Statement of Operations
Stock-based compensation for awards issued is reflected in the following line items in our Condensed Consolidated Statements of Operations:
 Three months ended April 30,Nine months ended April 30,
 2024202320242023
Cost of sales$67,000 141,000 $480,000 452,000 
Selling, general and administrative expenses313,000 3,896,000 4,480,000 5,559,000 
Research and development expenses24,000 89,000 278,000 287,000 
Stock-based compensation expense before CEO transition costs404,000 4,126,000 5,238,000 6,298,000 
CEO transition costs related to equity-classified stock-based awards— — — 3,764,000 
Total stock-based compensation expense before income tax benefit404,000 4,126,000 5,238,000 10,062,000 
Estimated income tax benefit(81,000)(915,000)(1,149,000)(1,701,000)
Net stock-based compensation expense$323,000 3,211,000 $4,089,000 8,361,000 
Summary of stock-based compensation expense by award type
Stock-based compensation expense, by award type, is summarized as follows:
Three months ended April 30,Nine months ended April 30,
2024202320242023
Stock options$11,000 22,000 $42,000 66,000 
Performance shares(662,000)335,000 280,000 690,000 
RSUs, restricted stock and share units1,040,000 3,738,000 4,850,000 5,449,000 
ESPP15,000 31,000 66,000 93,000 
Stock-based compensation expense before CEO transition costs404,000 4,126,000 5,238,000 6,298,000 
CEO transition costs related to equity-classified stock-based awards— — — 3,764,000 
Total stock-based compensation expense before income tax benefit404,000 4,126,000 5,238,000 10,062,000 
Estimated income tax benefit(81,000)(915,000)(1,149,000)(1,701,000)
Net stock-based compensation expense$323,000 3,211,000 $4,089,000 8,361,000 
Summary of the Plan's activity relating to stock options
The following table summarizes the Plan's activity:
 Awards
(in Shares)
Weighted Average
Exercise Price
Weighted Average
Remaining Contractual
Term (Years)
Aggregate
Intrinsic Value
Outstanding at July 31, 2023240,510 $23.96   
Expired/canceled(6,250)24.31   
Outstanding at October 31, 2023234,260 23.95   
Expired/canceled(9,680)24.25   
Outstanding at January 31, 2024224,580 23.93   
Expired/canceled(54,430)28.68 
Outstanding at April 30, 2024170,150 $22.42 3.97$— 
Exercisable at April 30, 2024147,450 $23.11 3.65$— 
Vested and expected to vest at April 30, 2024168,498 $22.46 3.95$— 
Summary of the Plan's activity relating to performance shares, RSUs, restricted stock and share units
The following table summarizes the Plan's activity relating to performance shares, RSUs, restricted stock, share units and other stock-based awards:
  Awards
(in Shares)
Weighted Average
Grant Date
Fair Value
Aggregate
Intrinsic Value
Outstanding at July 31, 2023 1,876,230 $13.21 
Granted 913,908 9.93 
Settled (296,198)16.03 
Canceled/Forfeited (41,814)15.80 
Outstanding at October 31, 2023 2,452,126 11.60 
Settled (383,565)10.64 
Canceled/Forfeited (41,927)12.78 
Outstanding at January 31, 20242,026,634 11.76 
Settled(9,642)14.10 
Canceled/Forfeited(625,155)8.47 
Outstanding at April 30, 2024 1,391,837 $13.22 $2,616,653 
  
Vested at April 30, 2024 451,975 $14.99 $849,713 
  
Vested and expected to vest at April 30, 2024 1,333,129 $13.19 $2,506,283